MGI
TEVA icon

Miller Global Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Miller Global Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Sell
4,469
-412
-8% -$13.7K 0.13% 154
2026
Q1 		$147K Sell
4,881
-89
-2% -$2.86K 0.13% 144
2025
Q4 		$155K Buy
+4,970
New +$122K 0.14% 140

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Miller Global Investments's TEVA Position: Q2 2026 in Review

Miller Global Investments reduced its Teva Pharmaceuticals (TEVA) stake by 8.4% in Q2 2026, selling an estimated $13.7K and leaving 4,469 shares worth $151K. The position accounts for 0.13% of the portfolio, ranked #154.

Miller Global Investments first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $155K in Q4 2025. 291 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Miller Global Investments held 4,469 shares of Teva Pharmaceuticals worth $151K as of Q2 2026.
  • Miller Global Investments sold 412 Teva Pharmaceuticals shares in Q2 2026, an estimated $13.7K.
  • Teva Pharmaceuticals made up 0.13% of Miller Global Investments's portfolio in Q2 2026, its #154 holding.
  • Miller Global Investments first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Teva Pharmaceuticals position peaked at $155K in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.